Cerevel Drug Hunters
Claim This Podcastby Dr. John Renger
Podcast Overview
<p>A Podcast Series from Cerevel’s Chief Scientific Officer, Dr. John Renger, dedicated to understanding the personal side of today’s neuroscience drug hunters.</p>
Language
🇺🇲
Publishing Since
5/1/2023
1 verified contact email on file for Cerevel Drug Hunters
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 9, 2024
Episode 15: Mark Bodenrader, Senior Vice President, Finance and Chief Accounting Officer
<p>On this episode of Drug Hunters, Dr. John Renger sits down with Cerevel’s <b>Senior Vice President, Finance and Chief Accounting Officer, Mark Bodenrader. </b>Mark is responsible for all aspects of Finance and Accounting and provides an inside look at his talented team’s ability to partner with the business to ensure seamless support. This way, Cerevel’s various functions can focus on what they do best, like bringing new therapies to patients. Mark also chats about the excitement of Cerevel’s early days, and what he looks forward to most about our future. </p>
June 3, 2024
Episode 14: Northeastern University Science Team Co-Ops Cohort 3
<p>On this episode of Drug Hunters, Dr. John Renger chats with <b>Cerevel’s 2024 Northeastern Co-Ops</b> to learn what sparked their interest in Cerevel, their predictions for the future in the world of drug discovery, and what they value most about the co-op program. </p>
April 2, 2024
Episode 13: TMEM175 Compound Team
<p>On the next episode of Drug Hunters, Dr. John Renger catches up with Cerevel’s own <b>TMEM175 Compound team</b> to learn more about the complexities that accompany screening this gene. We hear about both the goals and challenges in this program. </p>
15 total episodes available
Deep-dive analytics for Cerevel Drug Hunters
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Cerevel Drug Hunters?
<p>A Podcast Series from Cerevel’s Chief Scientific Officer, Dr. John Renger, dedicated to understanding the personal side of today’s neuroscience drug hunters.</p> - How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.